Barone Samuel B. 4
4 · Gemini Therapeutics, Inc. /DE · Filed Apr 14, 2021
Insider Transaction Report
Form 4
Barone Samuel B.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-12+255,212→ 255,212 totalExercise: $12.59Exp: 2031-04-11→ Common Stock (255,212 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, April 12, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.